| 1 |
Ali FE, Ibrahim IM, Ghogar OM, Abd-alhameed EK, Althagafy HS, Hassanein EH. Therapeutic interventions target the NLRP3 inflammasome in ulcerative colitis: Comprehensive study. World J Gastroenterol 2023; 29(6): 1026-1053 [DOI: 10.3748/wjg.v29.i6.1026] [Reference Citation Analysis]
|
| 2 |
Liu F, Yao Y, Wang Q, Zhang F, Wang M, Zhu C, Lin C. Nigakinone alleviates DSS-induced experimental colitis via regulating bile acid profile and FXR/NLRP3 signaling pathways. Phytother Res 2023;37:15-34. [PMID: 36054406 DOI: 10.1002/ptr.7588] [Reference Citation Analysis]
|
| 3 |
Wang Q, Wang M, Li N, Chen S, Ma H, Lu Z, Liu F, Lin C, Zhu C. A comparative study of Liandan Xiaoyan Formula metabolic profiles in control and colitis rats by UPLC-Q-TOF-MS combined with chemometrics. Journal of Pharmaceutical and Biomedical Analysis 2023;223:115115. [DOI: 10.1016/j.jpba.2022.115115] [Reference Citation Analysis]
|
| 4 |
Zhang K, Lu Z, Wang Q, Liu F, Wang M, Lin C, Zhu C. Pharmacokinetic Study of Four Major Bioactive Components of Liandan Xiaoyan Formula in Ulcerative Colitis and Control Rats Using UPLC-MS/MS. Front Pharmacol 2022;13:936846. [DOI: 10.3389/fphar.2022.936846] [Reference Citation Analysis]
|
| 5 |
Yue Q, Xu Y, Lin L, Hoi MPM. Canthin-6-one (CO) from Picrasma quassioides (D.Don) Benn. ameliorates lipopolysaccharide (LPS)-induced astrocyte activation and associated brain endothelial disruption. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154108] [Reference Citation Analysis]
|
| 6 |
Fabregat-Safont D, Mata-Pesquera M, Barneo-Muñoz M, Martinez-Garcia F, Mardal M, Davidsen AB, Sancho JV, Hernández F, Ibáñez M. In-depth comparison of the metabolic and pharmacokinetic behaviour of the structurally related synthetic cannabinoids AMB-FUBINACA and AMB-CHMICA in rats. Commun Biol 2022;5:161. [PMID: 35210552 DOI: 10.1038/s42003-022-03113-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Zhang K, Wang M, Yao Y, Huang T, Liu F, Zhu C, Lin C. Pharmacokinetic study of seven bioactive components of Xiaoyan Lidan Formula in cholestatic and control rats using UPLC-MS/MS. Biomed Pharmacother 2021;139:111523. [PMID: 33831838 DOI: 10.1016/j.biopha.2021.111523] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
